Source: International Congress 2015 – Pulmonary hypertension: management



Rating:

Share or cite this content

Citations should be made in the following way:
Beatriz Gsrcia Aranda (London, United Kingdom), Beatriz Garcia-Aranda, Aleksander Kempny, Marina Revilla-Martinez, Carl Harries, Lisa Parfitt, Rafael Alonso-Gonzalez, Laura Price, Konstatinos Dimopoulos, John Wort. Relation of the novel pulmonary hypertension emPHasis10 quality of life score to markers of disease severity. Eur Respir J 2015; 46: Suppl. 59, 3776

Member's Comments

No comment yet.

Related content which might interest you: EmPHasis-10 is associated with clinical outcome measures in pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Relationship of quality of life and life expectancy with tolerance to physical exercises and cardio respiratory parameters in patients with pulmonary arterial hypertension Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 The influence of psycho-social factors in the evolution of pulmonary hypertension patients Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Pulmonary arterial hypertension: the burden of disease and impact on quality of life Source: Eur Respir Rev 2015; 24: 621-629 Year: 2015 Measurement of quality of life in pulmonary hypertension and its significance Source: Eur Respir J 2006 Oct 01;28(4):808-815 Year: 2006 Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension Source: Eur Respir J 2011; 38: 608-616 Year: 2011 Anxiety and depression are highly prevalent in pulmonary hypertension and might improve with target therapy Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Examination about what determine quality of life (QOL) and the association between QOL and therapeutic intervention for patients with chronic thromboembolitic pulmonary hypertension (CTEPH) Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Correlations between clinical variables and quality of life in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Assessment of smoking effect on quality of life in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 456s Year: 2002 Quality of life and physical functioning in chronic thromboembolic pulmonary hypertension (CTEPH):  the impact of treatment Source: International Congress 2017 – PAH and CTEPH Year: 2017 emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension Source: Eur Respir J 2014; 43: 1106-1113 Year: 2014 Severity of disease and health-related quality of life in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 513s Year: 2005 Effects of sitting time on dyspnea, quality of life, and BODE score in chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Quality of life in patients with chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2016; 48: 526-537 Year: 2016 Sleep desaturation and pulmonary hypertension determine sleep-related quality of life and depression in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Predictors of health-related quality of life in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 66s Year: 2006 Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study Source: ERJ Open Res, 7 (3) 00617-2020; 10.1183/23120541.00617-2020 Year: 2021